• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成骨细胞前体细胞中 Hdac3 的缺失会增加骨保护素的表达,从而提高全身胰岛素敏感性。

Loss of Hdac3 in osteoprogenitors increases bone expression of osteoprotegerin, improving systemic insulin sensitivity.

机构信息

Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, Georgia.

Department of Orthopaedic Surgery, Medical College of Georgia, Augusta University, Augusta, Georgia.

出版信息

J Cell Physiol. 2018 Apr;233(4):2671-2680. doi: 10.1002/jcp.26148. Epub 2017 Sep 12.

DOI:10.1002/jcp.26148
PMID:28840938
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5741476/
Abstract

Type 2 diabetes is an emerging global health epidemic. Foundations for new therapies are arising from understanding interactions between body systems. Bone-derived factors that reduce RANKL (receptor activator of NF-kappa B ligand) signaling in the liver may prevent insulin resistance and the onset of type 2 diabetes. Here we demonstrate that deletion of the epigenetic regulator, Hdac3, in Osx1-expressing osteoprogenitors prevents insulin resistance induced by high fat diet by increasing serum and skeletal gene expression levels of osteoprotegerin (Opg), a natural inhibitor of RANKL signaling. Removal of one Opg allele in mice lacking Hdac3 in Osx1+ osteoprogenitors increases the insulin resistance of the Hdac3-deficient mice on a high fat diet. Thus, Hdac3-depletion in osteoblasts increases expression of Opg, subsequently preserving insulin sensitivity. The Hdac inhibitor vorinostat also increased Opg transcription and histone acetylation of the Opg locus. These results define a new mechanism by which bone regulates systemic insulin sensitivity.

摘要

2 型糖尿病是一种正在出现的全球健康流行症。新疗法的基础来自于对身体系统相互作用的理解。骨源性因子可降低肝脏中 RANKL(核因子 κB 配体受体激活剂)信号,从而预防胰岛素抵抗和 2 型糖尿病的发生。在这里,我们证明了在表达 Osx1 的成骨前体细胞中删除表观遗传调节剂 Hdac3,通过增加血清和骨骼中骨保护素(Opg)的基因表达水平,可预防高脂肪饮食引起的胰岛素抵抗,Opg 是 RANKL 信号的天然抑制剂。在缺乏 Hdac3 的小鼠中去除一个 Opg 等位基因,会增加缺乏 Hdac3 的成骨前体细胞中 Osx1+的小鼠在高脂肪饮食下的胰岛素抵抗。因此,成骨细胞中 Hdac3 的耗竭会增加 Opg 的表达,从而维持胰岛素敏感性。组蛋白去乙酰化酶抑制剂伏立诺他也增加了 Opg 转录和 Opg 基因座的组蛋白乙酰化。这些结果定义了一种新的机制,即骨骼调节全身胰岛素敏感性。

相似文献

1
Loss of Hdac3 in osteoprogenitors increases bone expression of osteoprotegerin, improving systemic insulin sensitivity.成骨细胞前体细胞中 Hdac3 的缺失会增加骨保护素的表达,从而提高全身胰岛素敏感性。
J Cell Physiol. 2018 Apr;233(4):2671-2680. doi: 10.1002/jcp.26148. Epub 2017 Sep 12.
2
The Transcriptional Modulator Interferon-Related Developmental Regulator 1 in Osteoblasts Suppresses Bone Formation and Promotes Bone Resorption.成骨细胞中的转录调节因子干扰素相关发育调节因子1抑制骨形成并促进骨吸收。
J Bone Miner Res. 2016 Mar;31(3):573-84. doi: 10.1002/jbmr.2720. Epub 2015 Oct 22.
3
Conditional deletion of Hdac3 in osteoprogenitor cells attenuates diet-induced systemic metabolic dysfunction.在骨祖细胞中条件性删除Hdac3可减轻饮食诱导的全身代谢功能障碍。
Mol Cell Endocrinol. 2015 Jul 15;410:42-51. doi: 10.1016/j.mce.2015.02.001. Epub 2015 Feb 7.
4
Histone Deacetylase 3 Deletion in Mesenchymal Progenitor Cells Hinders Long Bone Development.组蛋白去乙酰化酶 3 在间质祖细胞中的缺失阻碍长骨发育。
J Bone Miner Res. 2017 Dec;32(12):2453-2465. doi: 10.1002/jbmr.3236. Epub 2017 Sep 18.
5
Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.衰老会增加基质/成骨细胞诱导的破骨细胞生成,并改变小鼠体内破骨细胞前体细胞库。
J Bone Miner Res. 2005 Sep;20(9):1659-68. doi: 10.1359/JBMR.050503. Epub 2005 May 2.
6
Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.肝素通过抑制骨保护素的活性来增强破骨细胞的骨吸收作用。
Bone. 2007 Aug;41(2):165-74. doi: 10.1016/j.bone.2007.04.190. Epub 2007 May 5.
7
Thrombin receptor deficiency leads to a high bone mass phenotype by decreasing the RANKL/OPG ratio.凝血酶受体缺乏通过降低RANKL/OPG比值导致高骨量表型。
Bone. 2015 Mar;72:14-22. doi: 10.1016/j.bone.2014.11.004. Epub 2014 Nov 18.
8
Expression of RANKL and OPG correlates with age-related bone loss in male C57BL/6 mice.RANKL和OPG的表达与雄性C57BL/6小鼠的年龄相关性骨质流失相关。
J Bone Miner Res. 2003 Feb;18(2):270-7. doi: 10.1359/jbmr.2003.18.2.270.
9
Wnt/β-catenin signaling in osteoblasts regulates global energy metabolism.成骨细胞中的Wnt/β-连环蛋白信号传导调节整体能量代谢。
Bone. 2017 Apr;97:175-183. doi: 10.1016/j.bone.2017.01.028. Epub 2017 Jan 23.
10
Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.成骨细胞产生的骨保护素是破骨细胞发育和功能的重要调节因子。
Endocrinology. 2000 Sep;141(9):3478-84. doi: 10.1210/endo.141.9.7634.

引用本文的文献

1
RANKL/RANK is required for cytokine-induced beta cell death; osteoprotegerin, a RANKL inhibitor, reverses rodent type 1 diabetes.RANKL/RANK 对于细胞因子诱导的β细胞死亡是必需的;骨保护素,一种 RANKL 抑制剂,可逆转啮齿动物 1 型糖尿病。
Sci Adv. 2023 Nov 3;9(44):eadf5238. doi: 10.1126/sciadv.adf5238. Epub 2023 Nov 1.
2
Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study.代谢性疾病中的表观遗传调控:机制及临床研究进展。
Signal Transduct Target Ther. 2023 Mar 2;8(1):98. doi: 10.1038/s41392-023-01333-7.
3
The Glucocorticoid Receptor in Osterix-Expressing Cells Regulates Bone Mass, Bone Marrow Adipose Tissue, and Systemic Metabolism in Female Mice During Aging.成骨细胞特异性表达的糖皮质激素受体调节衰老雌性小鼠的骨量、骨髓脂肪组织和全身代谢
J Bone Miner Res. 2022 Feb;37(2):285-302. doi: 10.1002/jbmr.4468. Epub 2021 Nov 24.
4
A Class I Histone Deacetylase Inhibitor Attenuates Insulin Resistance and Inflammation in Palmitate-Treated C2C12 Myotubes and Muscle of HF/HFr Diet Mice.I类组蛋白去乙酰化酶抑制剂可减轻棕榈酸处理的C2C12肌管和高脂/高果糖饮食小鼠肌肉中的胰岛素抵抗和炎症。
Front Pharmacol. 2020 Dec 10;11:601448. doi: 10.3389/fphar.2020.601448. eCollection 2020.
5
Hdac3 deletion in myeloid progenitor cells enhances bone healing in females and limits osteoclast fusion via Pmepa1.在髓系祖细胞中删除 Hdac3 通过 Pmepa1 增强女性骨愈合并限制破骨细胞融合。
Sci Rep. 2020 Dec 11;10(1):21804. doi: 10.1038/s41598-020-78364-5.
6
Bromodomain Protein BRD4 Accelerates Glucocorticoid Dysregulation of Bone Mass and Marrow Adiposis by Modulating H3K9 and Foxp1.溴结构域蛋白 BRD4 通过调节 H3K9 和 Foxp1 加速糖皮质激素对骨量和骨髓脂肪化的失调。
Cells. 2020 Jun 19;9(6):1500. doi: 10.3390/cells9061500.
7
The Senolytic Drug Navitoclax (ABT-263) Causes Trabecular Bone Loss and Impaired Osteoprogenitor Function in Aged Mice.衰老细胞清除剂药物维托克洛司(ABT - 263)导致老年小鼠小梁骨丢失和骨祖细胞功能受损。
Front Cell Dev Biol. 2020 May 20;8:354. doi: 10.3389/fcell.2020.00354. eCollection 2020.
8
Hepatic Osteodystrophy-Molecular Mechanisms Proposed to Favor Its Development.肝性骨营养不良-有利于其发展的分子机制。
Int J Mol Sci. 2019 May 24;20(10):2555. doi: 10.3390/ijms20102555.

本文引用的文献

1
Histone deacetylase 3 supports endochondral bone formation by controlling cytokine signaling and matrix remodeling.组蛋白去乙酰化酶3通过控制细胞因子信号传导和基质重塑来支持软骨内骨形成。
Sci Signal. 2016 Aug 9;9(440):ra79. doi: 10.1126/scisignal.aaf3273.
2
Association of osteoprotegerin with impaired glucose regulation and microalbuminuria: the REACTION study.骨保护素与血糖调节受损及微量白蛋白尿的关联:REACTION研究
BMC Endocr Disord. 2015 Dec 1;15:75. doi: 10.1186/s12902-015-0067-5.
3
Determinants of bone strength and quality in diabetes mellitus in humans.人类糖尿病中骨强度和质量的决定因素。
Bone. 2016 Jan;82:28-34. doi: 10.1016/j.bone.2015.07.027. Epub 2015 Jul 26.
4
Osteoprotegerin and Denosumab Stimulate Human Beta Cell Proliferation through Inhibition of the Receptor Activator of NF-κB Ligand Pathway.骨保护素和地诺单抗通过抑制核因子κB受体激活剂配体途径刺激人β细胞增殖。
Cell Metab. 2015 Jul 7;22(1):77-85. doi: 10.1016/j.cmet.2015.05.021. Epub 2015 Jun 18.
5
A Single 60 mg Dose of Denosumab Might Improve Hepatic Insulin Sensitivity in Postmenopausal Nondiabetic Severe Osteoporotic Women.单次60毫克剂量的地诺单抗可能会改善绝经后非糖尿病重度骨质疏松女性的肝脏胰岛素敏感性。
Int J Endocrinol. 2015;2015:352858. doi: 10.1155/2015/352858. Epub 2015 Mar 19.
6
Conditional deletion of Hdac3 in osteoprogenitor cells attenuates diet-induced systemic metabolic dysfunction.在骨祖细胞中条件性删除Hdac3可减轻饮食诱导的全身代谢功能障碍。
Mol Cell Endocrinol. 2015 Jul 15;410:42-51. doi: 10.1016/j.mce.2015.02.001. Epub 2015 Feb 7.
7
Osterix-Cre transgene causes craniofacial bone development defect.骨形成蛋白转录因子-1(Osterix)-Cre转基因导致颅面骨发育缺陷。
Calcif Tissue Int. 2015 Feb;96(2):129-37. doi: 10.1007/s00223-014-9945-5. Epub 2014 Dec 31.
8
Regulation of energy metabolism by the skeleton: osteocalcin and beyond.骨骼对能量代谢的调节作用:骨钙素及其他。
Arch Biochem Biophys. 2014 Nov 1;561:137-46. doi: 10.1016/j.abb.2014.05.022. Epub 2014 Jun 2.
9
In vivo analysis of the contribution of bone resorption to the control of glucose metabolism in mice.在体分析骨吸收对小鼠葡萄糖代谢控制的作用。
Mol Metab. 2013 Aug 15;2(4):498-504. doi: 10.1016/j.molmet.2013.08.004. eCollection 2013.
10
In vivo assessment of bone quality in postmenopausal women with type 2 diabetes.2型糖尿病绝经后女性骨质量的体内评估
J Bone Miner Res. 2014 Apr;29(4):787-95. doi: 10.1002/jbmr.2106.